Newsroom

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will publish financial results for the third quarter 2026 and provide a business update on Tuesday, November 3, 2026.About Precision BioSciences, Inc.Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving l...

BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of Pascal Aeschlimann as Vice President of Asia Pacific, effective November 2, 2026. Mr. Aeschlimann, who led STAAR’s commercial expansion across Asia and the Middle East from 2002 to 2010, returns after more than a decade building and leading...

BILLERICA, Mass.--(BUSINESS WIRE)--Entegris, Inc. (NASDAQ: ENTG), today reported its financial results for the Company’s third quarter ended September 26, 2026. Dave Reeder, Entegris’ President and Chief Executive Officer, said: “Entegris is executing well against an attractive long-term opportunity, driven by increasing semiconductor complexity, rising materials intensity, and investment in leading-edge technologies. Our ability to deliver the performance, quality, and reliability our customer...

TORONTO--(BUSINESS WIRE)--Cosm Medical co-led revision of CPT® Category III codes 0559T/0560T, letting US providers report the work of personalizing Gynethotics™ pessaries....

WALL, N.J.--(BUSINESS WIRE)--New Jersey Resources schedules fiscal 2026 fourth quarter and year-end earnings call for 10 a.m. ET on November 19, 2026....

MIAMI--(BUSINESS WIRE)--TelevisaUnivision, the world's leading Spanish-language media company, today announced financial results for the third quarter ended September 30, 2026. Please visit the company’s Investor Relations website at investors.televisaunivision.com to view the financial results and earnings materials. The company will conduct a conference call today to discuss its financial results at 11:00 a.m. ET/ 8:00 a.m. PT. The call will be available via webcast at investors.televisaunivi...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the publication of results from a multinational survey examining symptoms, interactions with health care professionals (HCPs) and treatment experiences to better understand consumer perspectives on dry eye. The findings showed that self-reported dry eye symptoms were more common than reported HCP diagnosis and h...

EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it will host an investor conference call on Thursday, November 12, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time to discuss its financial results for the second quarter 2027. The Company will report its financial results prior to market open that same morning. Investor Conference Call Details DA...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the third quarter ended September 30, 2026, and provided recent corporate updates. “We are pleased with the continued progress made across our pipeline during the third quarter, as we advance nuzefatide pevedotin in the Phase 2...